Table 1.
Patient demographics at baseline
| FM
|
DPN/PHN
|
SCI
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pregabalin, mg/d
|
Placebo (N=937) |
Pregabalin, mg/d
|
Placebo (N=1,532) |
Pregabalin, mg/d | Placebo (N=175) |
||||||
| 300 (N=686) |
450 (N=687) |
Flex (N=250) |
150 (N=427) |
300 (N=875) |
600 (N=861) |
Flex (N=704) |
Flex (N=181) |
||||
| Sex, n (%) | |||||||||||
| Male | 52 (7.6) |
47 (6.8) |
24 (9.6) |
81 (8.6) |
227 (53.2) |
491 (56.1) |
492 (57.1) |
326 (46.3) |
824 (53.8) |
144 (79.6) |
146 (83.4) |
| Female | 634 (92.4) |
640 (93.2) |
226 (90.4) |
856 (91.4) |
200 (46.8) |
384 (43.9) |
369 (42.9) |
378 (53.7) |
708 (46.2) |
37 (20.4) |
29 (16.6) |
| Race, n (%) | |||||||||||
| White | 599 (87.3) |
598 (87.0) |
0 (0.0) |
602 (64.2) |
411 (96.3) |
677 (77.4) |
737 (85.6) |
296 (42.1) |
1,101 (71.9) |
109 (60.2) |
109 (62.3) |
| Black | 23 (3.4) |
23 (3.3) |
0 (0.0) |
19 (2.0) |
7 (1.6) |
30 (3.4) |
39 (4.5) |
13 (1.9) |
57 (3.7) |
6 (3.3) |
8 (4.6) |
| Asian/other | 64 (9.3) |
66 (9.6) |
250 (100.0) |
316 (33.7) |
9 (2.1) |
168 (19.2) |
85 (9.9) |
395 (56.1) |
374 (24.4) |
66 (36.5) |
58 (33.1) |
| Age, years, mean (SD) | 48.9 (10.7) |
48.9 (11.4) |
47.9 (12.0) |
48.3 (11.6) |
65.3 (12.3) |
64.2 (12.3) |
61.1 (10.9) |
60.6 (10.5) |
62.4 (11.7) |
47.7 (13.5) |
47.2 (14.1) |
Abbreviations: DPN, diabetic peripheral neuropathy; Flex, flexible dosing; FM, fibromyalgia; PHN, postherpetic neuralgia; SCI, spinal cord injury; SD, standard deviation; d, day.